Study Suggests Link Between Type 2 Diabetes and Low Melatonin

MAY 17, 2013
Women with low levels of melatonin may be at a higher risk for developing type 2 diabetes, according to a recent study published in the April 3, 2013, issue of the Journal of the American Medical Association.

The study included 370 women from the U.S. Nurses’ Health Study who developed type 2 diabetes from 2000 to 2012 and 370 non-diabetic controls. Melatonin levels were measured through urine and blood samples before the development of diabetes. When analyzing the relationship between melatonin and diabetes development, the researchers evaluated other risk factors such as demographics, eating habits, and sleep patterns.

Women with the lowest levels of melatonin were 2.17 times more likely to develop type 2 diabetes than women with the highest melatonin levels.

“While there is a correlation between melatonin and insulin resistance, we cannot tell from this study if low melatonin is the cause,” said Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City, in a press release. “We are far away from melatonin as a treatment.”

The authors conclude that more research is needed to determine if low melatonin levels are a risk factor for type 2 diabetes in the general population.


SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.